JB Bio 2 ApS: Financial statements 2020
CVR: 41041722
Source: annual report 2020, Danish Business Authority
02/01/2020 – 31/12/2020
JB Bio 2 ApS (CVR 41041722) has filed annual accounts for 2020. In 2020, the company reported a gross profit of DKK -9,375 and a net result of DKK -9,375. Equity in the 2020 report amounted to DKK 34,625. The solvency ratio was 86%.
- Gross Profit
- DKK -9,375
- Profit/Loss
- DKK -9,375
- Equity
- DKK 34,625
- Total Assets
- DKK 40,250
Official annual report
How creditworthy is JB Bio 2 ApS?
See the CDS score and get a full credit report with recommended credit limit and payment terms.
Read about the CDS scoreEvents in 2020
As of January 2, 2020, Revisionsfirmaet Seiersen Revision I/S has been appointed auditor of JB Bio 2 ApS.
As of January 2, 2020, Jannick Dyrløv Bendtsen is registered as adm. dir. of JB Bio 2 ApS.
As of January 2, 2020, Jannick Dyrløv Bendtsen is registered as an owner of JB Bio 2 ApS with an ownership share of 100%.
JB Bio 2 ApS was founded on January 2, 2020.
About JB Bio 2 ApS
JB Bio 2 ApS is a Danish company of the type Anpartsselskab based in Horsens, founded in 2020. The company is registered under the industry Ikke-finansielle holdingselskaber. The management consists of Jannick Dyrløv Bendtsen. The company is owned by Jannick Dyrløv Bendtsen. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -58,700 and a net result of DKK -7,715,676 compared with DKK 27,177,154 the year before. Equity in the 2025 report amounted to DKK 17,959,153.